Mariusz Waldemar Szkudlinski
Has grant
Chief Scientific Officer and Executive Vice President
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Mariusz Waldemar Szkudlinski is the Chief Scientific Officer and Executive Vice President at Trophogen in the United States. His research focuses on hormone action, particularly in relation to autoantibody mimicry at the thyrotropin receptor. He has published several articles contributing to the understanding of these complex interactions in endocrinology.
Recent Grants
Grant: Close
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.
Open Date: 2018-08-01
Close Date: 2023-08-31
Grant: Close
Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle
Open Date: 2017-09-18
Close Date: 2023-03-31
Grant: Close
Novel Recombinant High-Affinity, Long- and Dual-Acting Equine CG Analogs for Improved and More Ethical Reproduction in Pigs and Cattle
Open Date: 2017-09-18
Close Date: 2018-03-31
Grant: Close
Development of Novel and Affordable Neoglycosylated, Long Acting Superactive Analog of Human FSH for Infertility
Open Date: 2017-08-22
Close Date: 2020-02-29
Grant: Close
Novel High Affinity VEGF Analogs For Targeted Imaging of Thyroid Cancer
Open Date: 2013-05-10
Close Date: 2016-04-30
Articles (1)
Year:
2022
Collaborators (1)
Christian Billesbølle
University of California, San Francisco
Make your next move.
Prepare your application
Review drafts before you send them.